Journal
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
Volume 42, Issue 2, Pages 421-432Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.iac.2021.12.005
Keywords
Aspirin-exacerbated respiratory disease; Aspirin; Desensitization; Eicosanoids; Mast cells; Anaphylaxis
Categories
Funding
- GlaxoSmithKline